drugset / Trial / NCT01815541

Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study

NCT01815541

Phase 2 Completed 30 enrolled Centre Hospitalier Universitaire, Amiens
NaSingle-groupOpen-labelTreatment

Summary

This is a biomedical research, prospective, mono centric, tolerance study Of the administration of subcutaneous teicoplanin in the treatment of osteoarticular infections.

Timeline

Start
2013-03
Primary completion
2015-06
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Teicoplanin Other / unclassified Subcutaneous

Indications